U.S., May 17 -- ClinicalTrials.gov registry received information related to the study (NCT06975891) titled 'Performance of Systane PRO Versus Refresh Optive Mega-3' on May 08.

Brief Summary: Single site, prospective, double-masked, randomized-controlled, cross-over study of the subjective and objective performance of 2 different eyedrops. Subjects will be assessed at a screening visit, and 3 follow-up visits. Clinical evaluations will include patient questionnaires.

Study Start Date: June 01

Study Type: INTERVENTIONAL

Condition: Dry Eye

Intervention: DRUG: Systane PRO

Lubricating Eyedrops

DRUG: Refresh Optive MEGA-3

Lubricating Eyedrops

Recruitment Status: RECRUITING

Sponsor: Scripps Poway Eyecare and Optometry

Published by HT ...